Published in Front Synaptic Neurosci on November 25, 2014
Fractal Dimension Analysis of Subcortical Gray Matter Structures in Schizophrenia. PLoS One (2016) 1.40
Targeting Oxidative Stress and Aberrant Critical Period Plasticity in the Developmental Trajectory to Schizophrenia. Schizophr Bull (2015) 0.95
Using model systems to understand errant plasticity mechanisms in psychiatric disorders. Nat Neurosci (2016) 0.80
Hippocampal-Prefrontal Interactions in Cognition, Behavior and Psychiatric Disease. Front Syst Neurosci (2016) 0.78
Stimulation of Synaptic Vesicle Exocytosis by the Mental Disease Gene DISC1 is Mediated by N-Type Voltage-Gated Calcium Channels. Front Synaptic Neurosci (2016) 0.77
Deletion of Rapgef6, a candidate schizophrenia susceptibility gene, disrupts amygdala function in mice. Transl Psychiatry (2015) 0.76
Alteration of Neuronal Excitability and Short-Term Synaptic Plasticity in the Prefrontal Cortex of a Mouse Model of Mental Illness. J Neurosci (2017) 0.75
Structural brain changes are associated with response of negative symptoms to prefrontal repetitive transcranial magnetic stimulation in patients with schizophrenia. Mol Psychiatry (2016) 0.75
Haploinsufficiency of the 22q11.2 microdeletion gene Mrpl40 disrupts short-term synaptic plasticity and working memory through dysregulation of mitochondrial calcium. Mol Psychiatry (2016) 0.75
Cortactin Is a Regulator of Activity-Dependent Synaptic Plasticity Controlled by Wingless. J Neurosci (2017) 0.75
Disruption of Ninjurin1 Leads to Repetitive and Anxiety-Like Behaviors in Mice. Mol Neurobiol (2016) 0.75
Loss-of-function mutation in Mirta22/Emc10 rescues specific schizophrenia-related phenotypes in a mouse model of the 22q11.2 deletion. Proc Natl Acad Sci U S A (2017) 0.75
Impaired hippocampal place cell dynamics in a mouse model of the 22q11.2 deletion. Nat Neurosci (2017) 0.75
Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research. Front Pharmacol (2017) 0.75
Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science (2008) 20.68
Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry (2010) 16.89
Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol (2007) 16.81
Short-term synaptic plasticity. Annu Rev Physiol (2002) 16.67
Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature (2012) 14.76
Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature (2012) 13.71
De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature (2012) 13.61
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet (2013) 13.17
Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet (2009) 12.96
A resilient, low-frequency, small-world human brain functional network with highly connected association cortical hubs. J Neurosci (2006) 12.34
Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet (2008) 12.18
Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron (2011) 10.61
Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet (2008) 10.52
Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry (2003) 10.44
Common variants conferring risk of schizophrenia. Nature (2009) 10.37
Strong association of de novo copy number mutations with sporadic schizophrenia. Nat Genet (2008) 10.19
De novo gene disruptions in children on the autistic spectrum. Neuron (2012) 9.69
Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature (2009) 9.47
Neuroligins and neurexins link synaptic function to cognitive disease. Nature (2008) 9.23
Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nat Rev Neurosci (2007) 8.76
Neurobiology of depression. Neuron (2002) 8.56
Critical period plasticity in local cortical circuits. Nat Rev Neurosci (2005) 8.31
Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature (2011) 8.25
Synaptic plasticity and memory: an evaluation of the hypothesis. Annu Rev Neurosci (2000) 8.20
Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature (2009) 8.12
Learning induces long-term potentiation in the hippocampus. Science (2006) 7.46
Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44
Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet (2002) 7.40
Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature (2009) 7.39
Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet (2000) 7.16
Autism spectrum disorders: developmental disconnection syndromes. Curr Opin Neurobiol (2007) 6.96
Neural synchrony in brain disorders: relevance for cognitive dysfunctions and pathophysiology. Neuron (2006) 6.84
The neural code between neocortical pyramidal neurons depends on neurotransmitter release probability. Proc Natl Acad Sci U S A (1997) 6.60
De novo mutations in schizophrenia implicate synaptic networks. Nature (2014) 6.59
Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Natl Acad Sci U S A (2002) 6.45
Cognitive neuroscience and the study of memory. Neuron (1998) 6.22
Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet (2009) 6.13
Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet (2010) 5.78
Postnatal neurodevelopmental disorders: meeting at the synapse? Science (2003) 5.71
Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc Natl Acad Sci U S A (1995) 5.62
High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry (1999) 5.54
Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling. Cell (2009) 5.34
Behavioural phenotyping assays for mouse models of autism. Nat Rev Neurosci (2010) 5.27
Neurophysiological and computational principles of cortical rhythms in cognition. Physiol Rev (2010) 5.24
DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science (2005) 5.20
Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci (2008) 5.12
Autism and abnormal development of brain connectivity. J Neurosci (2004) 4.93
Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell (1999) 4.93
The genetics of autism spectrum disorders and related neuropsychiatric disorders in childhood. Am J Psychiatry (2010) 4.92
De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry (2011) 4.91
Synaptic theory of working memory. Science (2008) 4.87
Functional connectivity and brain networks in schizophrenia. J Neurosci (2010) 4.81
Schizophrenia and affective disorders--cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am J Hum Genet (2001) 4.77
Genomewide association studies: history, rationale, and prospects for psychiatric disorders. Am J Psychiatry (2009) 4.74
Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet (2004) 4.71
Redistribution of synaptic efficacy between neocortical pyramidal neurons. Nature (1996) 4.68
Working memory: theories, models, and controversies. Annu Rev Psychol (2011) 4.68
Exome sequencing supports a de novo mutational paradigm for schizophrenia. Nat Genet (2011) 4.67
Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron (2011) 4.66
Synaptic computation. Nature (2004) 4.63
Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature (2007) 4.59
Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci (1997) 4.57
The beginning of the end for the Kraepelinian dichotomy. Br J Psychiatry (2005) 4.51
Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat Neurosci (2009) 4.32
Prefrontal cortex and basal ganglia control access to working memory. Nat Neurosci (2007) 4.21
Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl) (2001) 4.03
Increased exonic de novo mutation rate in individuals with schizophrenia. Nat Genet (2011) 4.01
Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med (2006) 4.00
Association within a family of a balanced autosomal translocation with major mental illness. Lancet (1990) 3.94
Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr Bull (2005) 3.93
Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring. Schizophr Bull (2009) 3.82
Synaptic mechanisms and network dynamics underlying spatial working memory in a cortical network model. Cereb Cortex (2000) 3.80
Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat Genet (2008) 3.76
Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome. J Neurosci (2006) 3.69
The primacy of cognition in schizophrenia. Am Psychol (2005) 3.64
Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory. Cell (2001) 3.55
De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia. Nat Genet (2012) 3.49
CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Mol Psychiatry (2007) 3.44
Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size. J Med Genet (2009) 3.33
Structural plasticity and memory. Nat Rev Neurosci (2004) 3.28
Long-term depression in the CNS. Nat Rev Neurosci (2010) 3.27
Synaptic plasticity at hippocampal mossy fibre synapses. Nat Rev Neurosci (2005) 3.26
Repeated cortico-striatal stimulation generates persistent OCD-like behavior. Science (2013) 3.26
Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder. Eur Child Adolesc Psychiatry (2010) 3.14
Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J Nerv Ment Dis (1994) 3.12
Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. Am J Psychiatry (2003) 3.12
Abnormal neural synchrony in schizophrenia. J Neurosci (2003) 3.05
Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function. Nature (2012) 2.99
Impaired hippocampal-prefrontal synchrony in a genetic mouse model of schizophrenia. Nature (2010) 2.92
Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophr Bull (2006) 2.92
Neuregulin-1 enhances depolarization-induced GABA release. Neuron (2007) 2.89
The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments. Am J Psychiatry (2007) 2.89
Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nat Rev Neurosci (2011) 2.89
Neural mechanisms of a genome-wide supported psychosis variant. Science (2009) 2.88
MicroRNA biogenesis: drosha can't cut it without a partner. Curr Biol (2005) 2.85
Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch Gen Psychiatry (2009) 2.82
Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome. Neuron (2005) 2.82
Medicine. The future of psychiatric research: genomes and neural circuits. Science (2010) 2.79
Regionally specific disturbance of dorsolateral prefrontal-hippocampal functional connectivity in schizophrenia. Arch Gen Psychiatry (2005) 2.78
Neural stem cell proliferation is decreased in schizophrenia, but not in depression. Mol Psychiatry (2006) 2.77